Last reviewed · How we verify
NCT05483231
The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants
NA trial testing Family integrated care intervention group in Very Low Birth Weight Infant in 64 participants. Status unknown.
30 April 2024
Quick facts
| Lead sponsor | Children's Hospital of Fudan University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 64 |
| Start date | 1 December 2023 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Family integrated care intervention group
- Routine nursing care group
Conditions studied
- Very Low Birth Weight Infant — all drugs for Very Low Birth Weight Infant →
Sponsor
Children's Hospital of Fudan University
Who can join
Adults 0 Hours to 24 Hours, any sex, with Very Low Birth Weight Infant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will explore the effect of Family integrated care (FICare) on the level of melatonin and other clinical outcomes in very low birth weight infants (VLBWIs) by integrating families into the neonatal intensive care unit (NICU) care team and participating in the daily care of VLBWIs, as well as the influence of FIcare on parents' outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05483231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Very Low Birth Weight Infant
Currently open trials in the same condition.
- NCT06555315 — Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic) · NA · recruiting
- NCT05308134 — Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM) · NA · recruiting
- NCT04640805 — Targeted Fortification of Pasteurized Donor Human Milk · NA · active not recruiting
- NCT05399667 — Assessment of Body Composition in Premature Children Submitted to an Early Stimulation Program · active not recruiting
- NCT04239508 — Swiss Neonatal Network & Follow-up Group · recruiting
Other Children's Hospital of Fudan University trials
Trials by the same sponsor.
- NCT04955821 — Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS · not yet recruiting
- NCT05862688 — A Cohort Study on Anti-microbial Stewardship in PICU · not yet recruiting
- NCT05595239 — Blood Purification in Septic Children · NA · not yet recruiting
- NCT07325903 — Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty · EARLY_PHASE1 · not yet recruiting
- NCT07141615 — Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of P · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05483231 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Fudan University
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing